Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Aortic and Vascular Graft Devices Pipeline Market Report Overview

Aortic Stent and Vascular Graft Devices include Aortic Stent Grafts and Vascular Grafts. The Aortic and Vascular Graft Devices pipeline market research report provides comprehensive information about the Aortic and Vascular Graft devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Vascular Grafts

·        Abdominal Aortic Stent Grafts

·        Aortic Stent Grafts

·        Thoracic Aortic Stent Grafts

·        Peripheral Vascular Grafts

·        Aortic Vascular Grafts

Key Territories ·        The US

·        Europe

·        China

·        Israel

·        Japan

·        Singapore

·        Canada

·        South Korea

·        India

·        Australia

Key Regulatory Paths ·        PMA

·        CE

·        NMPA

·        Shonin

·        HSA

·        MDL

·        ICAC

Leading Companies ·        3DT Holdings LLC

·        Acro Biomedical Co Ltd

·        Affluent Medical SASU

·        Andes University

·        Angiograft LLC

·        Angiolutions UG

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Aortic and Vascular Graft Devices Pipeline Market by Segments

The key segments in the Aortic and Vascular Graft devices pipeline market are Vascular Grafts, Abdominal Aortic Stent Grafts, Aortic Stent Grafts, Thoracic Aortic Stent Grafts, Peripheral Vascular Grafts, and Aortic Vascular Grafts. As of October 2023, Vascular Grafts have the most pipeline products.

Aortic and Vascular Graft Devices Pipeline Market Analysis by Segments, 2023 (%)

Aortic and Vascular Graft Devices Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Aortic and Vascular Graft Devices Pipeline Market

Download a Free Report Sample

Aortic and Vascular Graft Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Aortic and Vascular Graft devices market are the US, Europe, China, Israel, Japan, Singapore, Canada, South Korea, India, and Australia. As of October 2023, the US has the highest number of pipeline products.

Aortic and Vascular Graft Devices Pipeline Market Analysis by Territories, 2023 (%)

Aortic and Vascular Graft Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Aortic and Vascular Graft Devices Pipeline Market

Download a Free Report Sample

Aortic and Vascular Graft Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Aortic and Vascular Graft devices pipeline market are PMA, CE, NMPA, Shonin, HSA, MDL, and ICAC. As of October 2023, PMA is the most followed pathway for pipeline products in the market.

Aortic and Vascular Graft Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Aortic and Vascular Graft Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Aortic and Vascular Graft Devices Pipeline Market

Download a Free Report Sample

Aortic and Vascular Graft Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Aortic and Vascular Graft devices pipeline market are 3DT Holdings LLC, Acro Biomedical Co Ltd, Affluent Medical SASU, Andes University, Angiograft LLC, and Angiolutions UG among others.

Acro Biomedical Co Ltd: It develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder. Acro Biomedica is headquartered in Indiana, the US.

Andes University Company Overview: Universidad de Los Andes (Andes University) is an educational institution that offers education and research services. The institute provides graduate and undergraduate programs, specialization programs, and research studies. It offers courses in areas such as architecture, art, humanities, engineering, science, accounting, history, political science, psychology, biology, and others. Andes University also provides courses in music, languages, culture, and environment. The institute provides various services such as a library and financial support to students. It operates through various faculties, laboratories, exhibitions, and a sports center. Andes University is headquartered in Bogota, Colombia.

Aortic and Vascular Graft Devices Pipeline Market Analysis by Companies, 2023

Aortic and Vascular Graft Devices Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Aortic and Vascular Graft Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Aortic and Vascular Graft Devices Pipeline Market Segments Outlook

  • Vascular Grafts
  • Abdominal Aortic Stent Grafts
  • Aortic Stent Grafts
  • Thoracic Aortic Stent Grafts
  • Peripheral Vascular Grafts
  • Aortic Vascular Grafts

Aortic and Vascular Graft Devices Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Israel
  • Japan
  • Singapore
  • Canada
  • South Korea
  • India
  • Australia

Aortic and Vascular Graft Devices Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • Shonin
  • HSA
  • MDL
  • ICAC

Scope

This report provides:

  • Extensive coverage of the Aortic and Vascular Graft Devices under development.
  • Review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in pipeline product development and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Aortic and Vascular Graft Devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3DT Holdings LLC
Acro Biomedical Co Ltd
Affluent Medical SASU
Andes University
Angiograft LLC
Angiolutions UG
APT Medical Inc
Aquedeon Medical Inc
Ariste Medical LLC
Artivion Inc
Aruga Technologies LLC
Ascyrus Medical LLC
Beijing Tianzhu Ruichang Medical Technology Co Ltd
BiFlow Medical Ltd
BioDGraft GmbH
BioIntegral Surgical Inc
BioLife4D Corp
BioQ Devices Pty Ltd
Biosurfaces Inc
Cardiojustable LLC (Inactive)
Cardiovate
Colorado Therapeutics, LLC
Cook Medical Inc
Cytograft Tissue Engineering Inc (Inactive)
Drexel University
DSM Biomedical BV
Endologix LLC
Endoluminal Sciences Pty Ltd.
Endomimetics LLC
Endoron Medical Ltd
EndoSpan Ltd
Eqalix, Inc.
Evasc Medical Systems Corp
FIT Biotech Oy (Inactive)
Gel-Del Technologies, Inc.
Hadassah Medical Center
Hangzhou Endonom Medtech Co Ltd
Humacyte Inc
Innoventric Ltd
Innovia LLC
Intressa Vascular SA
Johns Hopkins University
JOTEC GmbH
Kawasumi Laboratories Inc
Lifetech Scientific (Shenzhen) Co Ltd
Lombard Medical Technologies Inc.
Lombard Medical Technologies Ltd (Inactive)
Lundquist
Medtronic Plc
Merit Medical Systems Inc
MicroPort Scientific Corp
Nationwide Children's Hospital
Northwestern University
Peca Labs Inc
PerMed Biomedical Engineering Co Ltd
PetVivo Holdings Inc
PQ Bypass Inc
Red Vascular Technologies LLC
RegenaGraft
RUA Vascular Ltd
Secant Group LLC
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Southern University of Science and Technology
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stanford University
STENTiT BV
Strait Access Technologies (Pty) Ltd
Terumo Aortic
Terumo Corp
Tgen Tech LLC
The Lundquist Institute
Transmural systems LLC
TriVascular Inc
TTK Healthcare Ltd
University of Arizona
University of Colorado Denver
University of Limerick
University of Louisville
University of Nebraska Medical Center
University of Pittsburgh
University of Toledo
Vascudyne Inc
Vascular Graft Solutions Ltd
VenoStent Inc
Venus Medtech Hangzhou Inc
Verigraft AB
VesselTek BioMedical LLC
VESSL Therapeutics Ltd
W. L. Gore & Associates Inc
Xeltis AG
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

1 Table of Contents 3

1.1 List of Tables 8

1.2 List of Figures 18

2 Introduction 19

2.1 Aortic and Vascular Graft Devices Overview 19

3 Products under Development 20

3.1 Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 20

3.2 Aortic and Vascular Graft Devices – Pipeline Products by Segment 21

3.3 Aortic and Vascular Graft Devices – Pipeline Products by Territory 22

3.4 Aortic and Vascular Graft Devices – Pipeline Products by Regulatory Path 24

3.5 Aortic and Vascular Graft Devices – Pipeline Products by Estimated Approval Date 25

3.6 Aortic and Vascular Graft Devices – Ongoing Clinical Trials 26

4 Aortic and Vascular Graft Devices – Pipeline Products under Development by Companies 27

4.1 Aortic and Vascular Graft Devices Companies – Pipeline Products by Stage of Development 27

4.2 Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 31

5 Aortic and Vascular Graft Devices Companies and Product Overview 35

5.1 3DT Holdings LLC Company Overview 35

5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.2 Acro Biomedical Co Ltd Company Overview 37

5.2.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.3 Affluent Medical SASU Company Overview 38

5.3.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 38

5.4 Andes University Company Overview 39

5.4.1 Andes University Pipeline Products & Ongoing Clinical Trials Overview 39

5.5 Angiograft LLC Company Overview 40

5.5.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 40

5.6 Angiolutions UG Company Overview 41

5.6.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 41

5.7 APT Medical Inc Company Overview 42

5.7.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.8 Aquedeon Medical Inc Company Overview 43

5.8.1 Aquedeon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.9 Ariste Medical LLC Company Overview 46

5.9.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 46

5.10 Artivion Inc Company Overview 47

5.10.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.11 Aruga Technologies LLC Company Overview 49

5.11.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.12 Ascyrus Medical LLC Company Overview 50

5.12.1 Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 50

5.13 Beijing Tianzhu Ruichang Medical Technology Co Ltd Company Overview 55

5.13.1 Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.14 BiFlow Medical Ltd Company Overview 56

5.14.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.15 BioDGraft GmbH Company Overview 57

5.15.1 BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview 57

5.16 BioIntegral Surgical Inc Company Overview 58

5.16.1 BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.17 BioLife4D Corp Company Overview 59

5.17.1 BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview 59

5.18 BioQ Devices Pty Ltd Company Overview 60

5.18.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.19 Biosurfaces Inc Company Overview 61

5.19.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 61

5.20 Cardiojustable LLC (Inactive) Company Overview 62

5.20.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

5.21 Cardiovate Company Overview 63

5.21.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 63

5.22 Colorado Therapeutics, LLC Company Overview 64

5.22.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 64

5.23 Cook Medical Inc Company Overview 65

5.23.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.24 Cytograft Tissue Engineering Inc (Inactive) Company Overview 71

5.24.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

5.25 Drexel University Company Overview 74

5.25.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 74

5.26 DSM Biomedical BV Company Overview 75

5.26.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 75

5.27 Endologix LLC Company Overview 76

5.27.1 Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.28 Endoluminal Sciences Pty Ltd. Company Overview 87

5.28.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 87

5.29 Endomimetics LLC Company Overview 88

5.29.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 88

5.30 Endoron Medical Ltd Company Overview 89

5.30.1 Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

5.31 EndoSpan Ltd Company Overview 90

5.31.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.32 Eqalix, Inc. Company Overview 94

5.32.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94

5.33 Evasc Medical Systems Corp Company Overview 96

5.33.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 96

5.34 FIT Biotech Oy (Inactive) Company Overview 97

5.34.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97

5.35 Gel-Del Technologies, Inc. Company Overview 99

5.35.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99

5.36 Hadassah Medical Center Company Overview 100

5.36.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 100

5.37 Hangzhou Endonom Medtech Co Ltd Company Overview 101

5.37.1 Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.38 Humacyte Inc Company Overview 106

5.38.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.39 Innoventric Ltd Company Overview 113

5.39.1 Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

5.40 Innovia LLC Company Overview 116

5.40.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 116

5.41 Intressa Vascular SA Company Overview 117

5.41.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview 117

5.42 Johns Hopkins University Company Overview 118

5.42.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 118

5.43 JOTEC GmbH Company Overview 119

5.43.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 119

5.44 Kawasumi Laboratories Inc Company Overview 128

5.44.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.45 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 129

5.45.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

5.46 Lombard Medical Technologies Inc. Company Overview 132

5.46.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 132

5.47 Lombard Medical Technologies Ltd (Inactive) Company Overview 136

5.47.1 Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 136

5.48 Lundquist Company Overview 137

5.48.1 Lundquist Pipeline Products & Ongoing Clinical Trials Overview 137

5.49 Medtronic Plc Company Overview 138

5.49.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 138

5.50 Merit Medical Systems Inc Company Overview 147

5.50.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.51 MicroPort Scientific Corp Company Overview 154

5.51.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 154

5.52 Nationwide Children’s Hospital Company Overview 156

5.52.1 Nationwide Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 156

5.53 Northwestern University Company Overview 159

5.53.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 159

5.54 Peca Labs Inc Company Overview 160

5.54.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 160

5.55 PerMed Biomedical Engineering Co Ltd Company Overview 161

5.55.1 PerMed Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

5.56 PetVivo Holdings Inc Company Overview 164

5.56.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 164

5.57 PQ Bypass Inc Company Overview 165

5.57.1 PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview 165

5.58 Red Vascular Technologies LLC Company Overview 168

5.58.1 Red Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 168

5.59 RegenaGraft Company Overview 169

5.59.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 169

5.60 RUA Vascular Ltd Company Overview 170

5.60.1 RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 170

5.61 Secant Group LLC Company Overview 173

5.61.1 Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview 173

5.62 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview 174

5.62.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.63 Southern University of Science and Technology Company Overview 180

5.63.1 Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 180

5.64 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 181

5.64.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 181

5.65 St. Jude Medical LLC Company Overview 182

5.65.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 182

5.66 Stanford University Company Overview 185

5.66.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 185

5.67 STENTiT BV Company Overview 186

5.67.1 STENTiT BV Pipeline Products & Ongoing Clinical Trials Overview 186

5.68 Strait Access Technologies (Pty) Ltd Company Overview 187

5.68.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

5.69 Terumo Aortic Company Overview 188

5.69.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 188

5.70 Terumo Corp Company Overview 197

5.70.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 197

5.71 Tgen Tech LLC Company Overview 198

5.71.1 Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview 198

5.72 The Lundquist Institute Company Overview 199

5.72.1 The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview 199

5.73 Transmural systems LLC Company Overview 200

5.73.1 Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 200

5.74 TriVascular Inc Company Overview 201

5.74.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 201

5.75 TTK Healthcare Ltd Company Overview 202

5.75.1 TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 202

5.76 University of Arizona Company Overview 203

5.76.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 203

5.77 University of Colorado Denver Company Overview 204

5.77.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 204

5.78 University of Limerick Company Overview 205

5.78.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 205

5.79 University of Louisville Company Overview 206

5.79.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 206

5.80 University of Nebraska Medical Center Company Overview 207

5.80.1 University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview 207

5.81 University of Pittsburgh Company Overview 208

5.81.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 208

5.82 University of Toledo Company Overview 209

5.82.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 209

5.83 Vascudyne Inc Company Overview 210

5.83.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview 210

5.84 Vascular Graft Solutions Ltd Company Overview 211

5.84.1 Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 211

5.85 VenoStent Inc Company Overview 214

5.85.1 VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview 214

5.86 Venus Medtech Hangzhou Inc Company Overview 217

5.86.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 217

5.87 Verigraft AB Company Overview 218

5.87.1 Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview 218

5.88 VesselTek BioMedical LLC Company Overview 219

5.88.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 219

5.89 VESSL Therapeutics Ltd Company Overview 220

5.89.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 220

5.90 W. L. Gore & Associates Inc Company Overview 221

5.90.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 221

5.91 Xeltis AG Company Overview 224

5.91.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 224

5.92 Zylox-Tonbridge Medical Technology Co Ltd Company Overview 225

5.92.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

6 Aortic and Vascular Graft Devices- Recent Developments 229

6.1 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 229

6.2 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report 229

6.3 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 231

6.4 Sep 01, 2023: Japan Lifeline Announces Changes in Organizations and Personnel 232

6.5 Aug 29, 2023: MicroPort CardioFlow Medtech Corp. Announces Change of Directors and Chairman 232

6.6 Aug 29, 2023: Microport Cardioflow Medtech Announces Change of Directors and Chairman 234

6.7 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 234

6.8 Aug 24, 2023: Endologix Announces that Lucas Buchanan Joins Board of Directors 234

6.9 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion 235

6.10 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees 235

6.11 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 235

6.12 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 236

6.13 Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure 236

6.14 Jul 11, 2023: Microport Scientific Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 236

6.15 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 236

6.16 May 18, 2023: Shanghai Kindly Medical Instruments Co. Announces Poll Results of Annual General Meeting & Payment of Final Dividend 236

6.17 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023 237

6.18 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 237

6.19 May 02, 2023: LeMaitre Q1 2023 financial results 238

6.20 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023 238

6.21 Apr 26, 2023: MicroPort announces annual results for 2022 239

6.22 Apr 12, 2023: Medtronic has a layoff in California 239

6.23 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023 239

6.24 Mar 29, 2023: Endovastec Announces Annual Results for 2022 240

6.25 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 241

6.26 Feb 23, 2023: LeMaitre Q4 2022 Financial Results 241

6.27 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023 242

6.28 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022 243

6.29 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023 244

6.30 Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022 244

6.31 Dec 22, 2022: Twenty years of weaving polyester vascular grafts 245

6.32 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 246

6.33 Dec 05, 2022: Meihua International Medical Technologies Appoints New CEO, CFO and Directors 246

6.34 Nov 23, 2022: Medtronic Reports Quarterly Earnings 247

6.35 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 247

6.36 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 253

6.37 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 253

6.38 Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022 253

6.39 Oct 26, 2022: The home of Getinge’s polyester vascular grafts 253

6.40 Oct 25, 2022: UH Harrington Heart & Vascular Institute performs first TRIOMPHE study case in Northeast Ohio 254

6.41 Oct 17, 2022: LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022 255

6.42 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022 255

7 Appendix 256

7.1 Methodology 256

7.2 About GlobalData 259

7.3 Contact Us 259

7.4 Disclaimer 259

Table

Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 20

Aortic and Vascular Graft Devices – Pipeline Products by Segment 21

Aortic and Vascular Graft Devices – Pipeline Products by Territory 22

Aortic and Vascular Graft Devices – Pipeline Products by Regulatory Path 24

Aortic and Vascular Graft Devices – Pipeline Products by Estimated Approval Date 25

Aortic and Vascular Graft Devices – Ongoing Clinical Trials 26

Aortic and Vascular Graft Devices Companies – Pipeline Products by Stage of Development 27

Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 31

3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 35

PVP Biological Patch – Product Status 35

PVP Biological Patch – Product Description 35

Small Peripheral Vessel Graft – Product Status 36

Small Peripheral Vessel Graft – Product Description 36

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

ACROARTERY – Product Status 37

ACROARTERY – Product Description 37

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 38

Kardiozis – Product Status 38

Kardiozis – Product Description 38

Andes University Pipeline Products & Ongoing Clinical Trials Overview 39

SiSgraft – Product Status 39

SiSgraft – Product Description 39

Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 40

Vascular Graft – Product Status 40

Vascular Graft – Product Description 40

Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 41

Vascular Graft (A3-Shield) – Product Status 41

Vascular Graft (A3-Shield) – Product Description 41

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Thoracic Aortic Stent – Product Status 42

Thoracic Aortic Stent – Product Description 42

Aquedeon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Duett Vascular Graft System – Product Status 43

Duett Vascular Graft System – Product Description 43

Aquedeon Medical Inc – Ongoing Clinical Trials Overview 44

Duett Vascular Graft System – A Pivotal Study of Duett Vascular Graft System 45

Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 46

Drug Eluting Vascular Graft – Product Status 46

Drug Eluting Vascular Graft – Product Description 46

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 47

Neo 2.0 – Product Status 47

Neo 2.0 – Product Description 47

Synergraft Xenograft Vascular Graft – Product Status 48

Synergraft Xenograft Vascular Graft – Product Description 48

Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Topograft – Product Status 49

Topograft – Product Description 49

Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 50

Ascyrus Medical Dissection Stent – Product Status 50

Ascyrus Medical Dissection Stent – Product Description 51

Ascyrus Medical LLC – Ongoing Clinical Trials Overview 52

Ascyrus Medical Dissection Stent – A Prospective, Single Arm, Multi-center Clinical Investigation to Evaluate the Safety and Effectiveness of AMDS in the Treatment of Acute DeBakey Type I Dissection: PERSEVERE 53

Ascyrus Medical Dissection Stent – Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study 53

Ascyrus Medical Dissection Stent – Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility, Safety and Performance Trial 53

Ascyrus Medical Dissection Stent – Dissected Aorta Repair through Stent Implantation (DARTS): A Post-market Registry 54

Ascyrus Medical Dissection Stent – Randomized Trial on Acutely Dissected Aorta Repair with Hemiarch Replacement With or Without Stent Implantation (RADAR Trial) 54

Beijing Tianzhu Ruichang Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Three-Branch Thoracic Aorta Stent Graft System – Product Status 55

Three-Branch Thoracic Aorta Stent Graft System – Product Description 55

BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

Nitinol Side Branch Stent – Product Status 56

Nitinol Side Branch Stent – Product Description 56

BioDGraft GmbH Pipeline Products & Ongoing Clinical Trials Overview 57

Biodegradable Graft – Arteriosclerosis – Product Status 57

Biodegradable Graft – Arteriosclerosis – Product Description 57

BioIntegral Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Non-valved Conduit – Product Status 58

Non-valved Conduit – Product Description 58

BioLife4D Corp Pipeline Products & Ongoing Clinical Trials Overview 59

Cardiac Graft – Product Status 59

Cardiac Graft – Product Description 59

BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

BioQ Aortic Stent Graft Assist – Product Status 60

BioQ Aortic Stent Graft Assist – Product Description 60

Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 61

BioFunc – APC Vascular Graft – Product Status 61

BioFunc – APC Vascular Graft – Product Description 61

Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62

Adjustable SPA Shunt – Product Status 62

Adjustable SPA Shunt – Product Description 62

Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 63

NeoVessel Vascular Graft – Product Status 63

NeoVessel Vascular Graft – Product Description 63

Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 64

Xenograft Implant – Peripheral Vascular Disease – Product Status 64

Xenograft Implant – Peripheral Vascular Disease – Product Description 64

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65

Zenith Eterna – Product Status 65

Zenith Eterna – Product Description 65

Zenith Fenestrated+ Endovascular Graft – Product Status 66

Zenith Fenestrated+ Endovascular Graft – Product Description 66

Zenith P-Branch – Product Status 66

Zenith P-Branch – Product Description 67

Cook Medical Inc – Ongoing Clinical Trials Overview 68

Zenith P-Branch – Zenith p-Branch Pivotal Study 69

Zenith Fenestrated+ Endovascular Graft – Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms 70

Zenith Fenestrated+ Endovascular Graft – Zenith Fenestrated+ Endovascular Graft Clinical Study 70

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

LifeJacket AAA Stent Graft – Product Status 71

LifeJacket AAA Stent Graft – Product Description 71

Lifeline TEBV – Lower Limb – Product Status 72

Lifeline TEBV – Lower Limb – Product Description 72

LifeLine TEBV – Pediatric – Product Status 72

LifeLine TEBV – Pediatric – Product Description 73

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 74

Hydrogel-Based Chemically-Eluting Shunt Prosthesis – Product Status 74

Hydrogel-Based Chemically-Eluting Shunt Prosthesis – Product Description 74

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 75

Small Diameter Vascular Graft – Product Status 75

Small Diameter Vascular Graft – Product Description 75

Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview 76

AFX2 Bifurcated Endograft System – Product Status 76

AFX2 Bifurcated Endograft System – Product Description 77

AFX3 – Product Status 77

AFX3 – Product Description 77

AFX4 – Product Status 78

AFX4 – Product Description 78

Nellix 3.5 – Product Status 78

Nellix 3.5 – Product Description 79

Nellix CHEVAS – Product Status 79

Nellix CHEVAS – Product Description 79

Nellix EVAS System – Product Status 80

Nellix EVAS System – Product Description 80

Nellix With Snorkels – Product Status 80

Nellix With Snorkels – Product Description 81

Next Gen EVAS – Product Status 81

Next Gen EVAS – Product Description 81

Paravisceral System – Product Status 82

Paravisceral System – Product Description 82

Ventana 2 – Product Status 82

Ventana 2 – Product Description 83

Xpand BX Covered Stent – Product Status 83

Xpand BX Covered Stent – Product Description 83

Endologix LLC – Ongoing Clinical Trials Overview 84

Nellix EVAS System – Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair 85

Nellix EVAS System – Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study 85

Nellix CHEVAS – Prospective, Multicenter, Non-randomized Study with Consecutive, Eligible Subject Enrollment at Each Site, for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms 86

Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 87

Stent-Graft With Adhesive Delivery Platform – Product Status 87

Stent-Graft With Adhesive Delivery Platform – Product Description 87

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 88

Stent Graft – Product Status 88

Stent Graft – Product Description 88

Endoron Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

Aortoseal – Product Status 89

Aortoseal – Product Description 89

EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Nexus Aortic Arch Stent Graft System – Product Status 90

Nexus Aortic Arch Stent Graft System – Product Description 90

EndoSpan Ltd – Ongoing Clinical Trials Overview 91

Nexus Aortic Arch Stent Graft System – A Multi-arm, Multi-center, Non-randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch 92

Nexus Aortic Arch Stent Graft System – A Non-Randomized, Prospective, Open-Label, Multi-Center, Observational Clinical Study to Further Evaluate Safety and Performance of the NEXUS Aortic Arch Stent Graft System 92

Nexus Aortic Arch Stent Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain” 92

Nexus Aortic Arch Stent Graft System – NEXUS Aortic Arch Stent Graft System Data Collection Study for Compassionate-Use Procedures 93

Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94

CardioVessel – Product Status 94

CardioVessel – Product Description 94

LCL Graft – Product Status 95

LCL Graft – Product Description 95

Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 96

TAS System – Product Status 96

TAS System – Product Description 96

FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 97

GTU X-Graft – Product Status 97

GTU X-Graft – Product Description 97

GTU X2-Graft – Product Status 98

GTU X2-Graft – Product Description 98

Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99

VasoGraft – Product Status 99

VasoGraft – Product Description 99

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 100

In Situ Weldable Hybrid Stent – Product Status 100

In Situ Weldable Hybrid Stent – Product Description 100

Hangzhou Endonom Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Product Status 101

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Product Description 101

WeFlow-Tbranch Stent Graft System – Product Status 102

WeFlow-Tbranch Stent Graft System – Product Description 102

Hangzhou Endonom Medtech Co Ltd – Ongoing Clinical Trials Overview 103

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Guo’s Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System 104

WeFlow-Arch Modeler Embedded Branch Stent Graft System – Guo’s Aortic Arch Reconstruction: The Prospective, Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study) 104

WeFlow-Tbranch Stent Graft System – Guo’s Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: A Multicenter Pilot Study (Graft Study) 105

WeFlow-Tbranch Stent Graft System – Guo’s Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System (GUEST Study) 105

WeFlow-Tbranch Stent Graft System – New Technology Clinical Study on the Safety and Efficacy of WeFlow-Tribranch Aortic Arch Stent Graft System in the Treatment of Patients with Aortic Arch Dissection 105

Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Humacyl Graft – CABG – Product Status 106

Humacyl Graft – CABG – Product Description 106

Humacyl Graft – Critical Limb Ischemia – Product Status 107

Humacyl Graft – Critical Limb Ischemia – Product Description 107

Humacyl Graft – Pediatric Heart Surgery – Product Status 107

Humacyl Graft – Pediatric Heart Surgery – Product Description 108

Humacyl Graft – Peripheral Artery Disease – Product Status 108

Humacyl Graft – Peripheral Artery Disease – Product Description 108

Humacyl Graft – Vascular Trauma – Product Status 109

Humacyl Graft – Vascular Trauma – Product Description 109

Humacyte Inc – Ongoing Clinical Trials Overview 110

Humacyl Graft – Vascular Trauma – A Compassionate Use Study of Humacyte’s Human Acellular Vessel for the Treatment of Patients with Critical Limb Ischemia and Vascular Trauma 111

Humacyl Graft – Vascular Trauma – A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacyte’s Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma 111

Humacyl Graft – Vascular Trauma – An Observational Multicenter Study to Evaluate the Safety and Efficacy of Humacyte’s Human Acellular Vessel in a Real World Setting for Arterial Replacement or Reconstruction in Ukrainian Patients with Life or Limb-threatening Vascular Trauma 111

Humacyl Graft – Peripheral Artery Disease – A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte’s Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-popliteal Bypass in Patients with Peripheral Arterial Disease 112

Innoventric Ltd Pipeline Products & Ongoing Clinical Trials Overview 113

Trillium – Product Status 113

Trillium – Product Description 113

Innoventric Ltd – Ongoing Clinical Trials Overview 114

Trillium – Prospective, Single Arm, Multi-center, First-in-human (FIH) Study to Assess the Safety and Performance of the Innoventric Trillium Stent Graft for the Treatment of Severe Tricuspid Regurgitation (TR) 115

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 116

4mm Vascular Graft – Product Status 116

4mm Vascular Graft – Product Description 116

Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview 117

Bifurcated Multilayer Flow Modulator Kit – Product Status 117

Bifurcated Multilayer Flow Modulator Kit – Product Description 117

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 118

Scaly Aortic Stent Graft – Product Status 118

Scaly Aortic Stent Graft – Product Description 118

JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 119

E-liac Stent Graft System – Product Status 119

E-liac Stent Graft System – Product Description 119

E-nside TAAA Stent Graft – Product Status 120

E-nside TAAA Stent Graft – Product Description 120

E-nya Thoracic Stent Graft – Product Status 120

E-nya Thoracic Stent Graft – Product Description 121

E-Ventus SX – Product Status 121

E-Ventus SX – Product Description 121

E-Vita Open Neo – Product Status 122

E-Vita Open Neo – Product Description 122

JOTEC GmbH – Ongoing Clinical Trials Overview 123

E-liac Stent Graft System – Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni- or Bilateral Aorto-iliac or Iliac Aneurysms 124

E-liac Stent Graft System – Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm with the Branched E-liac Stent Graft 124

E-nya Thoracic Stent Graft – CONFORM-TAA – A Post-market Clinical Follow-up Study in Patients with a Descending Thoracic Aortic Aneurysm or Penetrating Aortic Ulcer (PAU) Treated with the E-nya Thoracic Stent Graft System 125

E-nya Thoracic Stent Graft – CONFORM-TAD- A Post-market Clinical Follow-up Study in Patients with Complicated Acute, Subacute or Chronic Type B Aortic Dissection with Double Lumen Treated with the E-nya Thoracic Stent Graft System 125

E-nside TAAA Stent Graft – INNER-B – A Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System 126

E-nside TAAA Stent Graft – INNER-B-APAC – Asian Pacific Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System 126

E-Vita Open Neo – A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS 127

E-Vita Open Neo – NEO – E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections 127

E-Vita Open Neo – NEOS-APAC – Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO 127

Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 128

Abdominal Aortic Aneurysm Stent Graft – Product Status 128

Abdominal Aortic Aneurysm Stent Graft – Product Description 128

Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Product Status 129

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Product Description 129

Lifetech Scientific (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview 130

G-Branch Thoracic-Abdominal Aorta Stent Graft System – Guo’s Renovisceral Artery Reconstruction-1: A Prospective, Multicenter, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a Multi-branched Stent Graft System for Thoracoabdominal Aortic Aneurysm (GUARANTEE Study) 131

Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 132

FEVAR – Product Status 132

FEVAR – Product Description 132

TEVAR – Product Status 133

TEVAR – Product Description 133

Lombard Medical Technologies Inc. – Ongoing Clinical Trials Overview 134

TEVAR – Scandinavian Trial of Uncomplicated Aortic Dissection Therapy 135

Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 136

Low Profile Stent Graft – Product Status 136

Low Profile Stent Graft – Product Description 136

Lundquist Pipeline Products & Ongoing Clinical Trials Overview 137

Thoracic-Abdominal Endoluminal Graft – Product Status 137

Thoracic-Abdominal Endoluminal Graft – Product Description 137

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 138

Endurant Evo AAA Stent Graft System – Product Status 138

Endurant Evo AAA Stent Graft System – Product Description 139

Unitary Manifold Stent Graft System – Product Status 139

Unitary Manifold Stent Graft System – Product Description 139

Valiant Mona LSA System – Product Status 140

Valiant Mona LSA System – Product Description 140

Valiant TAAA Stent Graft System – Product Status 140

Valiant TAAA Stent Graft System – Product Description 141

Medtronic Plc – Ongoing Clinical Trials Overview 142

Valiant Mona LSA System – Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending Thoracic Aortic Aneurysms and Chronic Dissections 143

Valiant TAAA Stent Graft System – Endograft Repair of Thoracoabdominal Aortic Aneurysms (TAAA) 144

Valiant TAAA Stent Graft System – Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms 144

Valiant TAAA Stent Graft System – Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms 144

Valiant TAAA Stent Graft System – Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms 145

Unitary Manifold Stent Graft System – Visceral Manifold and Unitary Device Study for the Repair of Thoracoabdominal Aortic Aneurysms 146

Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 147

Self-expanding Covered Stent Graft – Product Status 147

Self-expanding Covered Stent Graft – Product Description 147

WRAPSODY Endovascular Stent Graft – Arteriovenous Fistula – Product Status 148

WRAPSODY Endovascular Stent Graft – Arteriovenous Fistula – Product Description 148

WRAPSODY Endovascular Stent Graft – Arteriovenous Graft – Product Status 148

WRAPSODY Endovascular Stent Graft – Arteriovenous Graft – Product Description 149

WRAPSODY Endovascular Stent Graft – Venous Occlusive Disease – Product Status 149

WRAPSODY Endovascular Stent Graft – Venous Occlusive Disease – Product Description 150

Merit Medical Systems Inc – Ongoing Clinical Trials Overview 151

WRAPSODY Endovascular Stent Graft – Venous Occlusive Disease – Prospective, Randomized, Controlled, Multicenter Study Comparing the Merit WRAPSODY Endovascular Stent Graft to Percutaneous Transluminal Angioplasty for Treatment of Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients: The WAVE Study 152

WRAPSODY Endovascular Stent Graft – Arteriovenous Fistula – Prospective, Multicenter, Observational Study to Evaluate the Merit WRAPSODY Endoprosthesis for Treatment of Stenosis or Occlusion within the Dialysis Outflow Circuit of an Arteriovenous (AVF) Fistula or AV Graft (AVG) (The WRAP Registry) 153

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 154

Aegis II Abdominal Aortic Stent Graft System – Product Status 154

Aegis II Abdominal Aortic Stent Graft System – Product Description 154

Coronary Stent Graft System – Product Status 155

Coronary Stent Graft System – Product Description 155

Nationwide Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 156

Second-Generation Tissue Engineered Vascular Graft – Product Status 156

Second-Generation Tissue Engineered Vascular Graft – Product Description 156

Nationwide Children’s Hospital – Ongoing Clinical Trials Overview 157

Second-Generation Tissue Engineered Vascular Graft – Prospective, Open-labelled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection 158

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 159

ePTFE Graft – Peripheral Arterial Disease – Product Status 159

ePTFE Graft – Peripheral Arterial Disease – Product Description 159

Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 160

exGraft II – Product Status 160

exGraft II – Product Description 160

PerMed Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

PerMed Branch Stent Graft – Product Status 161

PerMed Branch Stent Graft – Product Description 161

PerMed Biomedical Engineering Co Ltd – Ongoing Clinical Trials Overview 162

PerMed Branch Stent Graft – A Prospective, Multicenter, Open, Randomized Controlled, Non Inferiority Clinical Trial to Evaluate the Safety and Efficacy the Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection 163

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 164

Peripheral Vascular Graft – Product Status 164

Peripheral Vascular Graft – Product Description 164

PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview 165

TORUS Stent Graft System – Product Status 165

TORUS Stent Graft System – Product Description 165

PQ Bypass Inc – Ongoing Clinical Trials Overview 166

TORUS Stent Graft System – The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization – 2 Trial: TORUS 2 167

Red Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 168

Non Modular Branched Endoprosthesis – Product Status 168

Non Modular Branched Endoprosthesis – Product Description 168

RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 169

RegenaVasc – Product Status 169

RegenaVasc – Product Description 169

RUA Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 170

Elast-Eon – Critical Limb Ischemia – Product Status 170

Elast-Eon – Critical Limb Ischemia – Product Description 170

Elast-Eon – Peripheral Artery Disease – Product Status 171

Elast-Eon – Peripheral Artery Disease – Product Description 171

Elast-Eon Large Bore Vascular Graft – Product Status 171

Elast-Eon Large Bore Vascular Graft – Product Description 172

Secant Group LLC Pipeline Products & Ongoing Clinical Trials Overview 173

Regenerez Graft – Product Status 173

Regenerez Graft – Product Description 173

Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

Aortic Vascular Intervention Device – Product Status 174

Aortic Vascular Intervention Device – Product Description 174

Cratos Branched Aortic Stent Graft System – Product Status 175

Cratos Branched Aortic Stent Graft System – Product Description 175

TIPS Stent Graft System – Product Status 175

TIPS Stent Graft System – Product Description 176

Shanghai MicroPort Endovascular MedTech Group Co Ltd – Ongoing Clinical Trials Overview 177

Cratos Branched Aortic Stent Graft System – A Prospective, Multicenter, Single-group Clinical Trial to Evaluate the Efficacy and Safety of the Cratos Branch Aortic Covered Stent System in the Treatment of Stanford Type B Aortic Dissection 178

Cratos Branched Aortic Stent Graft System – Evaluation of Cratos Branch Stent Graft System in Treatment of Descending Aorta Lesions 178

TIPS Stent Graft System – A Prospective, Multicenter, Single-group, Target-value Trial to Evaluate the Safety and Efficacy of Tips Coated Stent System in the Treatment of Portal Hypertension 179

Southern University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 180

Artificial Blood Vessel – Product Status 180

Artificial Blood Vessel – Product Description 180

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 181

Aortic Stent Graft – Product Status 181

Aortic Stent Graft – Product Description 181

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 182

Amplatzer AAA Vascular Graft – Product Status 182

Amplatzer AAA Vascular Graft – Product Description 182

Amplatzer Peripheral Vascular Graft – Product Status 183

Amplatzer Peripheral Vascular Graft – Product Description 183

Amplatzer TAA Vascular Graft – Product Status 183

Amplatzer TAA Vascular Graft – Product Description 184

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 185

SDF-Eluting Vascular Conduit – Product Status 185

SDF-Eluting Vascular Conduit – Product Description 185

STENTiT BV Pipeline Products & Ongoing Clinical Trials Overview 186

Regenerative Stent – Product Status 186

Regenerative Stent – Product Description 186

Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 187

TEVAR/EVAR Molding Balloon – Product Status 187

TEVAR/EVAR Molding Balloon – Product Description 187

Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 188

BoulEVARd Stent – Product Status 188

BoulEVARd Stent – Product Description 188

RelayBranch Thoracic Stent-Graft System – Product Status 189

RelayBranch Thoracic Stent-Graft System – Product Description 189

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Status 189

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Product Description 190

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Status 190

RelayPro Thoracic Stent-Graft System – Blunt Traumatic Aortic Injury – Product Description 191

Thoracoabdominal Hybrid Device – Product Status 191

Thoracoabdominal Hybrid Device – Product Description 191

TREOVANCE Abdominal Stent Graft With Navitel Delivery System – Product Status 192

TREOVANCE Abdominal Stent Graft With Navitel Delivery System – Product Description 192

Terumo Aortic – Ongoing Clinical Trials Overview 193

TREOVANCE Abdominal Stent Graft With Navitel Delivery System – Anatomical Feasibility of an Off-the-shelf Scalloped Stent-graft for Infrarenal Abdominal Aneurysm with a Hostile Neck (ReSTHoNe Study) 194

RelayBranch Thoracic Stent-Graft System – A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery 195

RelayBranch Thoracic Stent-Graft System – Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System 195

RelayBranch Thoracic Stent-Graft System – ENDOBARC-S Study: “Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain” 195

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – A Prospective, Multi-center, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection 196

RelayPro Thoracic Stent-Graft System – Acute Complicated Type B Thoracic Aortic Dissection – Thoraflex Hybrid and Relay Extension Post-Approval Study 196

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 197

Hybrid Stent Graft – Product Status 197

Hybrid Stent Graft – Product Description 197

Tgen Tech LLC Pipeline Products & Ongoing Clinical Trials Overview 198

TxGuard – Product Status 198

TxGuard – Product Description 198

The Lundquist Institute Pipeline Products & Ongoing Clinical Trials Overview 199

Multi-Branched Stent Graft – Product Status 199

Multi-Branched Stent Graft – Product Description 199

Transmural systems LLC Pipeline Products & Ongoing Clinical Trials Overview 200

Transcatheter Cavopulmonary Bypass Endograft – Product Status 200

Transcatheter Cavopulmonary Bypass Endograft – Product Description 200

TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 201

Ovation Thoracic Stent Graft System – Product Status 201

Ovation Thoracic Stent Graft System – Product Description 201

TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 202

Chitra Vascular Graft – Product Status 202

Chitra Vascular Graft – Product Description 202

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 203

Expansible Ascending Aortic Graft – Product Status 203

Expansible Ascending Aortic Graft – Product Description 203

University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 204

Shape Memory Polymer Arterial Stent – Product Status 204

Shape Memory Polymer Arterial Stent – Product Description 204

University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 205

Cardiovascular Graft – Product Status 205

Cardiovascular Graft – Product Description 205

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 206

Vascular Graft System – Product Status 206

Vascular Graft System – Product Description 206

University of Nebraska Medical Center Pipeline Products & Ongoing Clinical Trials Overview 207

Aortic Stent Graft – Product Status 207

Aortic Stent Graft – Product Description 207

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 208

Biomimetic Vascular Graft – Product Status 208

Biomimetic Vascular Graft – Product Description 208

University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 209

Aortic Endograft Fenestration Device – Product Status 209

Aortic Endograft Fenestration Device – Product Description 209

Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview 210

TRUE Graft for Coronary Artery Bypass – Product Status 210

TRUE Graft for Coronary Artery Bypass – Product Description 210

Vascular Graft Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 211

VEST – Product Status 211

VEST – Product Description 211

Vascular Graft Solutions Ltd – Ongoing Clinical Trials Overview 212

VEST – A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support 213

VenoStent Inc Pipeline Products & Ongoing Clinical Trials Overview 214

SelfWrap – Product Status 214

SelfWrap – Product Description 214

Glossary

Figures

Aortic and Vascular Graft Devices – Pipeline Products by Stage of Development 20

Aortic and Vascular Graft Devices – Pipeline Products by Segment 21

Aortic and Vascular Graft Devices – Pipeline Products by Territory 22

Aortic and Vascular Graft Devices – Pipeline Products by Regulatory Path 24

Aortic and Vascular Graft Devices – Pipeline Products by Estimated Approval Date 25

Aortic and Vascular Graft Devices – Ongoing Clinical Trials 26

Frequently asked questions

Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Aortic and Vascular Graft Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.